JMS-17-2
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-123918-50 mg |
| CAS # | 1380392-05-1 |
| Pricing | 50 mg, USD $400.0 |
| Biological Activity | JMS-17-2 is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM. JMS-17-2 impairs metastatic seeding and colonization of breast cancer cells[1]. |
| Purity | 99.59% |
| MWt | 419.95 |
| Formula | C₂₅H₂₆ClN₃O |